vs

Side-by-side financial comparison of Essent Group Ltd. (ESNT) and Penumbra Inc (PEN). Click either name above to swap in a different company.

Penumbra Inc is the larger business by last-quarter revenue ($385.4M vs $312.4M, roughly 1.2× Essent Group Ltd.). Essent Group Ltd. runs the higher net margin — 49.6% vs 12.3%, a 37.3% gap on every dollar of revenue. On growth, Penumbra Inc posted the faster year-over-year revenue change (22.1% vs -0.8%). Essent Group Ltd. produced more free cash flow last quarter ($848.7M vs $68.0M). Over the past eight quarters, Penumbra Inc's revenue compounded faster (17.6% CAGR vs 2.3%).

Essentra PLC is a supplier of plastic and fibre products. The company operates internationally from headquarters in Kidlington, Oxfordshire. It is listed on the London Stock Exchange.

Penumbra, Inc. is an American medical device company headquartered in Alameda, California. The company was founded by Arani Bose and Adam Elsesser in 2004. It manufactures devices for interventional therapies to treat vascular conditions such as stroke and aneurysm.

ESNT vs PEN — Head-to-Head

Bigger by revenue
PEN
PEN
1.2× larger
PEN
$385.4M
$312.4M
ESNT
Growing faster (revenue YoY)
PEN
PEN
+23.0% gap
PEN
22.1%
-0.8%
ESNT
Higher net margin
ESNT
ESNT
37.3% more per $
ESNT
49.6%
12.3%
PEN
More free cash flow
ESNT
ESNT
$780.6M more FCF
ESNT
$848.7M
$68.0M
PEN
Faster 2-yr revenue CAGR
PEN
PEN
Annualised
PEN
17.6%
2.3%
ESNT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ESNT
ESNT
PEN
PEN
Revenue
$312.4M
$385.4M
Net Profit
$155.0M
$47.3M
Gross Margin
68.0%
Operating Margin
59.1%
15.4%
Net Margin
49.6%
12.3%
Revenue YoY
-0.8%
22.1%
Net Profit YoY
-7.7%
40.6%
EPS (diluted)
$1.61
$1.20

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ESNT
ESNT
PEN
PEN
Q4 25
$312.4M
$385.4M
Q3 25
$311.8M
$354.7M
Q2 25
$319.1M
$339.5M
Q1 25
$317.6M
$324.1M
Q4 24
$315.0M
$315.5M
Q3 24
$316.6M
$301.0M
Q2 24
$312.9M
$299.4M
Q1 24
$298.4M
$278.7M
Net Profit
ESNT
ESNT
PEN
PEN
Q4 25
$155.0M
$47.3M
Q3 25
$164.2M
$45.9M
Q2 25
$195.3M
$45.3M
Q1 25
$175.4M
$39.2M
Q4 24
$167.9M
$33.7M
Q3 24
$176.2M
$29.5M
Q2 24
$203.6M
$-60.2M
Q1 24
$181.7M
$11.0M
Gross Margin
ESNT
ESNT
PEN
PEN
Q4 25
68.0%
Q3 25
67.8%
Q2 25
66.0%
Q1 25
66.6%
Q4 24
66.8%
Q3 24
66.5%
Q2 24
54.4%
Q1 24
65.0%
Operating Margin
ESNT
ESNT
PEN
PEN
Q4 25
59.1%
15.4%
Q3 25
63.9%
13.8%
Q2 25
72.4%
12.0%
Q1 25
65.2%
12.4%
Q4 24
61.9%
13.6%
Q3 24
65.6%
11.7%
Q2 24
76.4%
-27.0%
Q1 24
71.6%
4.3%
Net Margin
ESNT
ESNT
PEN
PEN
Q4 25
49.6%
12.3%
Q3 25
52.7%
12.9%
Q2 25
61.2%
13.3%
Q1 25
55.2%
12.1%
Q4 24
53.3%
10.7%
Q3 24
55.6%
9.8%
Q2 24
65.1%
-20.1%
Q1 24
60.9%
3.9%
EPS (diluted)
ESNT
ESNT
PEN
PEN
Q4 25
$1.61
$1.20
Q3 25
$1.67
$1.17
Q2 25
$1.93
$1.15
Q1 25
$1.69
$1.00
Q4 24
$1.59
$0.88
Q3 24
$1.65
$0.75
Q2 24
$1.91
$-1.55
Q1 24
$1.70
$0.28

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ESNT
ESNT
PEN
PEN
Cash + ST InvestmentsLiquidity on hand
$186.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$5.8B
$1.4B
Total Assets
$7.4B
$1.8B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ESNT
ESNT
PEN
PEN
Q4 25
$186.9M
Q3 25
$321.0M
Q2 25
$421.8M
Q1 25
$376.1M
Q4 24
$324.4M
Q3 24
$280.5M
Q2 24
$288.3M
Q1 24
$223.1M
Stockholders' Equity
ESNT
ESNT
PEN
PEN
Q4 25
$5.8B
$1.4B
Q3 25
$5.7B
$1.4B
Q2 25
$5.7B
$1.3B
Q1 25
$5.7B
$1.2B
Q4 24
$5.6B
$1.2B
Q3 24
$5.6B
$1.1B
Q2 24
$5.4B
$1.2B
Q1 24
$5.2B
$1.2B
Total Assets
ESNT
ESNT
PEN
PEN
Q4 25
$7.4B
$1.8B
Q3 25
$7.4B
$1.7B
Q2 25
$7.2B
$1.7B
Q1 25
$7.2B
$1.6B
Q4 24
$7.1B
$1.5B
Q3 24
$7.1B
$1.5B
Q2 24
$6.7B
$1.5B
Q1 24
$6.6B
$1.6B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ESNT
ESNT
PEN
PEN
Operating Cash FlowLast quarter
$856.1M
$86.5M
Free Cash FlowOCF − Capex
$848.7M
$68.0M
FCF MarginFCF / Revenue
271.7%
17.7%
Capex IntensityCapex / Revenue
2.4%
4.8%
Cash ConversionOCF / Net Profit
5.52×
1.83×
TTM Free Cash FlowTrailing 4 quarters
$1.5B
$174.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ESNT
ESNT
PEN
PEN
Q4 25
$856.1M
$86.5M
Q3 25
$215.9M
$58.3M
Q2 25
$189.5M
$44.9M
Q1 25
$221.6M
$49.0M
Q4 24
$861.5M
$51.1M
Q3 24
$229.2M
$56.5M
Q2 24
$188.7M
$22.6M
Q1 24
$216.9M
$38.3M
Free Cash Flow
ESNT
ESNT
PEN
PEN
Q4 25
$848.7M
$68.0M
Q3 25
$210.6M
$42.0M
Q2 25
$188.8M
$29.4M
Q1 25
$221.3M
$35.5M
Q4 24
$854.8M
$45.7M
Q3 24
$228.7M
$51.0M
Q2 24
$187.6M
$18.1M
Q1 24
$212.5M
$32.5M
FCF Margin
ESNT
ESNT
PEN
PEN
Q4 25
271.7%
17.7%
Q3 25
67.5%
11.8%
Q2 25
59.2%
8.7%
Q1 25
69.7%
11.0%
Q4 24
271.3%
14.5%
Q3 24
72.2%
16.9%
Q2 24
60.0%
6.0%
Q1 24
71.2%
11.7%
Capex Intensity
ESNT
ESNT
PEN
PEN
Q4 25
2.4%
4.8%
Q3 25
1.7%
4.6%
Q2 25
0.2%
4.6%
Q1 25
0.1%
4.2%
Q4 24
2.1%
1.7%
Q3 24
0.2%
1.8%
Q2 24
0.3%
1.5%
Q1 24
1.5%
2.1%
Cash Conversion
ESNT
ESNT
PEN
PEN
Q4 25
5.52×
1.83×
Q3 25
1.31×
1.27×
Q2 25
0.97×
0.99×
Q1 25
1.26×
1.25×
Q4 24
5.13×
1.52×
Q3 24
1.30×
1.91×
Q2 24
0.93×
Q1 24
1.19×
3.48×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ESNT
ESNT

Mortgage Insurance Segment$192.4M62%
Other$120.0M38%

PEN
PEN

Thrombectomy$254.7M66%
Other$130.7M34%

Related Comparisons